288 related articles for article (PubMed ID: 36537075)
1. Fibronectin in hyperglycaemia and its potential use in the treatment of diabetic foot ulcers: A review.
Kanta J; Zavadakova A; Sticova E; Dubsky M
Int Wound J; 2023 May; 20(5):1750-1761. PubMed ID: 36537075
[TBL] [Abstract][Full Text] [Related]
2. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
[TBL] [Abstract][Full Text] [Related]
3. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds.
Loots MA; Lamme EN; Zeegelaar J; Mekkes JR; Bos JD; Middelkoop E
J Invest Dermatol; 1998 Nov; 111(5):850-7. PubMed ID: 9804349
[TBL] [Abstract][Full Text] [Related]
4. Effect of Negative Pressure Wound Therapy on Cellular Fibronectin and Transforming Growth Factor-β1 Expression in Diabetic Foot Wounds.
Yang SL; Zhu LY; Han R; Sun LL; Dou JT
Foot Ankle Int; 2017 Aug; 38(8):893-900. PubMed ID: 28459181
[TBL] [Abstract][Full Text] [Related]
5. Bioactive-Glass-Based Materials with Possible Application in Diabetic Wound Healing: A Systematic Review.
Vargas Guerrero M; Aendekerk FMA; de Boer C; Geurts J; Lucchesi J; Arts JJC
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256225
[TBL] [Abstract][Full Text] [Related]
6. Stem Cells and Angiogenesis: Implications and Limitations in Enhancing Chronic Diabetic Foot Ulcer Healing.
Rai V; Moellmer R; Agrawal DK
Cells; 2022 Jul; 11(15):. PubMed ID: 35892584
[TBL] [Abstract][Full Text] [Related]
7. Negative pressure wound therapy in grade 1 and 2 diabetic foot ulcers: A randomized controlled study.
Maranna H; Lal P; Mishra A; Bains L; Sawant G; Bhatia R; Kumar P; Beg MY
Diabetes Metab Syndr; 2021; 15(1):365-371. PubMed ID: 33524646
[TBL] [Abstract][Full Text] [Related]
8. Effect of matrix metalloproteinases on the healing of diabetic foot ulcer: A systematic review.
Zhang WQ; Tang W; Hu SQ; Fu XL; Wu H; Shen WQ; Chen HL
J Tissue Viability; 2023 Feb; 32(1):51-58. PubMed ID: 36513539
[TBL] [Abstract][Full Text] [Related]
9. The role of stem cells in the treatment of diabetic foot ulcers.
Blumberg SN; Berger A; Hwang L; Pastar I; Warren SM; Chen W
Diabetes Res Clin Pract; 2012 Apr; 96(1):1-9. PubMed ID: 22142631
[TBL] [Abstract][Full Text] [Related]
10. Growth factors for treating diabetic foot ulcers.
Martí-Carvajal AJ; Gluud C; Nicola S; Simancas-Racines D; Reveiz L; Oliva P; Cedeño-Taborda J
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD008548. PubMed ID: 26509249
[TBL] [Abstract][Full Text] [Related]
11. Role of fibroblast plasticity and heterogeneity in modulating angiogenesis and healing in the diabetic foot ulcer.
Rai V; Moellmer R; Agrawal DK
Mol Biol Rep; 2023 Feb; 50(2):1913-1929. PubMed ID: 36528662
[TBL] [Abstract][Full Text] [Related]
12. Altered ECM deposition by diabetic foot ulcer-derived fibroblasts implicates fibronectin in chronic wound repair.
Maione AG; Smith A; Kashpur O; Yanez V; Knight E; Mooney DJ; Veves A; Tomic-Canic M; Garlick JA
Wound Repair Regen; 2016 Jul; 24(4):630-43. PubMed ID: 27102877
[TBL] [Abstract][Full Text] [Related]
13. [Research progress of dipeptidyl peptidase 4 inhibitors on healing of chronic diabetic foot ulcers].
Gao Y; Liang Y; Ran X
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2018 May; 32(5):630-633. PubMed ID: 29806355
[TBL] [Abstract][Full Text] [Related]
14. Male or female sex: considerations and translational aspects in diabetic foot ulcer research using rodent models.
Rai V; Agrawal DK
Mol Cell Biochem; 2023 Aug; 478(8):1835-1845. PubMed ID: 36574098
[TBL] [Abstract][Full Text] [Related]
15. Functionalised biomaterials as synthetic extracellular matrices to promote vascularisation and healing of diabetic wounds.
Browne S; Petit N; Quondamatteo F
Cell Tissue Res; 2024 Feb; 395(2):133-145. PubMed ID: 38051351
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of tissue engineering products for the management of neuropathic diabetic foot ulcers: an interim analysis.
Frykberg RG; Cazzell SM; Arroyo-Rivera J; Tallis A; Reyzelman AM; Saba F; Warren L; Stouch BC; Gilbert TW
J Wound Care; 2016 Jul; 25(Sup7):S18-S25. PubMed ID: 29027848
[TBL] [Abstract][Full Text] [Related]
17. Role of fibronectin in chronic venous diseases: A review.
Kanta J; Zavadakova A
Vasc Med; 2020 Dec; 25(6):588-597. PubMed ID: 32877311
[TBL] [Abstract][Full Text] [Related]
18. Role of matrix metalloproteinases in diabetic foot ulcers: Potential therapeutic targets.
Fu K; Zheng X; Chen Y; Wu L; Yang Z; Chen X; Song W
Front Pharmacol; 2022; 13():1050630. PubMed ID: 36339630
[TBL] [Abstract][Full Text] [Related]
19. Translational development of ABCB5
Kerstan A; Dieter K; Niebergall-Roth E; Klingele S; Jünger M; Hasslacher C; Daeschlein G; Stemler L; Meyer-Pannwitt U; Schubert K; Klausmann G; Raab T; Goebeler M; Kraft K; Esterlechner J; Schröder HM; Sadeghi S; Ballikaya S; Gasser M; Waaga-Gasser AM; Murphy GF; Orgill DP; Frank NY; Ganss C; Scharffetter-Kochanek K; Frank MH; Kluth MA
Stem Cell Res Ther; 2022 Sep; 13(1):455. PubMed ID: 36064604
[TBL] [Abstract][Full Text] [Related]
20. Clinical benefits of small intestinal submucosa extracellular matrix and review of the evidence.
Jeffery S
J Wound Care; 2023 Jan; 32(Sup1a):S11-S19. PubMed ID: 36744602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
